Abstract
Background
Onychomycosis by Neoscytalidium constitutes chronic infection of the nails, and its frequency has increased in recent decades. Currently, no effective standard treatment exists and literature data remain scarce. This work aimed to conduct a pilot project of combined treatment for this infection.
Methods
Thirty patients were divided into three treatment groups: oral terbinafine plus ciclopirox nail lacquer twice a week; ciclopirox nail lacquer twice a week; and ciclopirox nail lacquer 5 days a week, all associated with nail abrasion when required, for 12 months, with 6 months posttreatment follow-up. Clinical and mycological criteria were used for evaluation.
Results
Twenty-five patients completed the study. Significant clinical lesion reduction in disease occurred in all three treatment groups: 21 patients (84 %) entered the study with more than 50 % of diseased nail plate, at the end of treatment, and at 6-month follow-up, 84 and 96 %, respectively, presented less than 25 % nail lesion. Negative microscopy was observed in 36 % of the patients at the end of treatment and in 24 % of the patients at 6-month follow-up. At treatment completion (12 months), culture was negative in 21 patients (84 %) and in 18 (72 %) at follow-up. It was not possible to establish any clinical or mycological statistical differences between groups (p > 0.05). Global medical evaluation upon treatment completion revealed that one patient (4 %) presented complete cure, 8 (32 %) presented partial cure, 16 (64 %) presented therapeutic failure. At the end of follow-up period, 6 patients (24 %) were considered to have recurrence/reinfection.
Conclusions
The results obtained at the 6-month period of follow-up showed marked improvement (96 % of clinical improvement and 72 % of negative culture) of the patients treated for onychomycosis caused by Neoscytalidium in the three tested groups with no statistical differences between them. Multicentric studies with greater number of patients enrolled are necessary to confirm these results.
Similar content being viewed by others
References
Ellis DH, Marley JE, Watson AB, Williams TG. Significance of non-dermatophyte moulds and yeast in onychomycosis. Dermatology. 1997;194:40–2.
Gupta AK, Jain HC, Lynde CW, MacDonald P, et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol. 2000;43:244–8.
Ellis DH, Watson AB, Marley JE, Williams TG. Non-dermatophyte in onychomycosis of the toenails. Br J Dermatol. 1997;136:490–3.
Pavlovic MD, Bulajic N, Huntley AC. Great toenail onychomycosis caused by Syncephalastrum racemosum. Dermatol Online J. 2006;12(1) From Dermatology Online Journal www.medscape.com Accessed: 03 Feb 2006.
Lacroix C, Kac G, Dubertret L, Morel P, et al. Scytalidiosis in Paris. France J Am Acad Dermatol. 2003;48:852–6.
Araújo AJG, Bastos OMP, Sousa MAJ, Oliveira JC. Occurrence of onychomycosis among patients attended in dermatology offices in the city of Rio de Janeiro. An Bras Dermatol. 2003;78(3):445–55.
Crous PW, Slippers B, Wingfield MJ, Rheeder J, et al. Phylogenetic lineages in the Botryosphaeriaceae. Stud Mycol. 2006;55:235–53.
Madrid H, Ruíz-Cendoya M, Cano J, Stchigel A, Orofino R, Guarro J. Genotyping and in vitro antifungal susceptibility of Neoscytalidium dimidiatum isolates from different origins. Int J Antimicrob Agents. 2009;34:351–4.
Tosti A, Peraccini BM, Lorenzi S. Onychomycosis caused by non-dermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 2000;42:217–24.
Elewski BE, Greer DL. Hendersonula toruloidea and Scytalidium hyalinum. Arch Dermatol. 1991;127:1041–4.
Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of non-dermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012;66:494–502.
Di Chiachio N, Kadunc BV, De Almeida ART, Madeira CL. Nail abrasion. J Cosmet Dermatol. 2003;2:150–2.
Cursi IB, Freitas LBCR, Neves MLP, Silva IC, Orofino-Costa R. Onychomycosis due to Scytalidium spp.: a clinical and epidemiologic study at a University Hospital in Rio de Janeiro. An Bras Dermatol. 2011;86(4):689–93.
Belloeuf L, Boisseau-Garsaud AM, et al. Nail disease due to Scytalidium in martinique (French West Indies). Ann Dermatol Venereol. 2004;13:245–9.
Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol. 2004;19:21–9.
Simonnet C, Berger F, Gantier JC. Epidemiology of superficial fungal diseases in French Guiana: a three-year retrospective analysis. Med Mycol. 2011;49:608–11.
Lacroix C, de Chauvin MF. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafina against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates. J Antimicrob Chemother. 2008;61:835–7.
Dunand J, Paugam A. In vitro susceptibility of isolates of Scytalidium spp. from superficial lesions against posaconazole. Pathol Biol (Paris). 2008;56:268–71.
Elinav H, Izhar U, Benenson S, Admon D, Hidalgo-Grass C, Polacheck I, Korem M. Invasive Scytalidium dimidiatum infection in an immunocompetent adult. J Clin Microbiol. 2009;47(4):1259–63.
Ikram A, Hussain W, Satti ML, Wiqar MA. Invasive infection in a young immunocompetent soldier caused by Scytalidium dimidiatum. J Coll Physicians Surg Pak. 2009;19(1):64–6.
Ruíz-Cendoya M, Madrid H, Pastor FJ, Mayayo E, Mariné M, Guarro J. Development of murine models of disseminated infection by Neoscytalidium dimidiatum. Med Mycol. 2010;48:681–6.
Gupta AK, Ryder JE, Summerbell RC. The diagnosis of non-dermatophyte mold onychomycosis. Int J Dermatol. 2003;42:272–3.
Arrese JE, Piérard-Franchimont C, Piérard GE. Scytalidium dimidiatum melanonychia and scaly plantar skin in four patients from the Maghreb: imported disease or outbreak in a Belgian mosque? Dermatology. 2001;202:183–5.
Conflict of interest
Authors have no relationship with industry for this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was conducted at Medical Mycology Laboratory, Pedro Ernesto University Hospital, Universidade do Estado do Rio de Janeiro.
Rights and permissions
About this article
Cite this article
Cursi, Í.B., Silva, R.T., Succi, I.B. et al. Onychomycosis Due to Neoscytalidium Treated with Oral Terbinafine, Ciclopirox Nail Lacquer and Nail Abrasion: A Pilot Study of 25 Patients. Mycopathologia 175, 75–82 (2013). https://doi.org/10.1007/s11046-012-9580-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-012-9580-5